Morgan Stanley’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48M | Buy |
|
|||||
|
2025
Q1 | $24M | Sell |
|
|||||
|
2024
Q4 | $20.9M | Sell |
|
|||||
|
2024
Q3 | $28.3M | Buy |
|
|||||
|
2024
Q2 | $12M | Sell |
|
|||||
|
2024
Q1 | $54.4M | Sell |
|
|||||
|
2023
Q4 | $54.7M | Buy |
|
|||||
|
2023
Q3 | $7.16M | Sell |
|
|||||
|
2023
Q2 | $16M | Sell |
|
|||||
|
2023
Q1 | $36.1M | Sell |
|
|||||
|
2022
Q4 | $26.6M | Buy |
|
|||||
|
2022
Q3 | $18.8M | Buy |
|
|||||
|
2022
Q2 | $14.1M | Buy |
|
|||||
|
2022
Q1 | $31.7M | Buy |
|
|||||
|
2021
Q4 | $3.67M | Sell |
|
|||||
|
2021
Q3 | $8.4M | Buy |
|
|||||
|
2021
Q2 | $3.13M | Buy |
|
|||||
|
2021
Q1 | $123K | Sell |
|
|||||
|
2020
Q4 | $675K | Buy |
|
|||||
|
2020
Q3 | $156K | Sell |
|
|||||
|
2020
Q2 | $190K | Buy |
|
|||||
|
2020
Q1 | $10K | Sell |
|
|||||
|
2019
Q4 | $235K | Sell |
|
|||||
|
2019
Q3 | $1.47M | Buy |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $57K | Buy |
|
|||||
|
2018
Q4 | $30K | Sell |
|
|||||
|
2018
Q3 | $233K | Sell |
|
|||||
|
2018
Q2 | $308K | Buy |
|
|||||
|
2018
Q1 | $242K | Buy |
|
|||||
|
2017
Q4 | $574K | Buy |
|
|||||
|
2017
Q3 | $341K | Buy |
|
|||||
|
2017
Q2 | $95K | Sell |
|
|||||
|
2017
Q1 | $127K | Sell |
|
|||||
|
2016
Q4 | $501K | Buy |
|
|||||
|
2016
Q3 | $4K | Buy |
|